Problem 7 - AP Biology Premium Prep 2021

Question

Neuronal ceroid lipofuscinosis (NCL) is a group of autosomal recessive diseases characterized by blindness, loss of cognitive and motor function, and early death. One of the genes that is mutated in this disease is CLN3. When functional CLN3 protein is absent, neurons die because of increased storage material in the cells, presumably because the lysosomes aren't working properly. What is a valid explanation as to why parents of children with this devastating disease can be completely normal? (A) Parents of the autosomal recessive disease must both be carriers of the mutation on the CLN3 gene. (B) Carriers of the CLN3 mutation genotype do not show the phenotype because one normal CLN3 allele is present to provide a functioning CLN3 protein. (C) Redundant proteins take over the function of the mutant CLN3 protein in the parents. (D) X inactivation prevents expression of the CLN3 mutated protein in the parents.

Step-by-Step Solution

Answer

(A) Parents of the autosomal recessive disease must both be carriers of the mutation on the CLN3 gene. (B) Carriers of the CLN3 mutation genotype do not show the phenotype because one normal CLN3 allele is present to provide a functioning CLN3 protein.

Step 1: Identifying the correct inheritance pattern

NCL is an autosomal recessive disorder. This means that an individual must have two copies of the mutated gene (one from each parent) to express the disease. Parents are only carriers if they have one normal gene and one mutated gene. Now let's analyze each given option:

Step 2: Analyzing option A

(A) Parents of the autosomal recessive disease must both be carriers of the mutation on the CLN3 gene. This statement is true for autosomal recessive disorders like NCL because both parents must be carriers (having one normal gene and one mutated gene) for their child to inherit two mutated genes and express the disease.

Step 3: Analyzing option B

(B) Carriers of the CLN3 mutation genotype do not show the phenotype because one normal CLN3 allele is present to provide a functioning CLN3 protein. This statement is also true because carriers with one normal and one mutated gene do not express the disease. The normal CLN3 allele produces enough functioning CLN3 protein to avoid the disease phenotype.

Step 4: Analyzing option C

(C) Redundant proteins take over the function of the mutant CLN3 protein in the parents. There is no evidence in the exercise to support this statement. Moreover, this statement does not match the inheritance pattern of autosomal recessive disorders.

Step 5: Analyzing option D

(D) X inactivation prevents expression of the CLN3 mutated protein in the parents. NCL is an autosomal recessive disorder, not an X-linked disorder. Therefore, this statement is not relevant to the discussion and is incorrect.

Step 6: Determining the correct answer

Both Option A and Option B are correct statements, as they correctly explain why parents of children with NCL can be completely normal: (A) Parents of the autosomal recessive disease must both be carriers of the mutation on the CLN3 gene. (B) Carriers of the CLN3 mutation genotype do not show the phenotype because one normal CLN3 allele is present to provide a functioning CLN3 protein.

Key Concepts

Neuronal ceroid lipofuscinosis (NCL)

Neuronal ceroid lipofuscinosis (NCL) is a group of rare neurodegenerative disorders, which are classified as autosomal recessive diseases. This means that the condition occurs when an individual inherits two copies of a mutated gene—one from each parent. NCL is characterized by the gradual loss of vital motor and cognitive functions, significant vision impairment leading to blindness, and unfortunately, can result in early mortality. The primary culprit behind this condition is the malfunctioning of lysosomes within the cells. Lysosomes are responsible for breaking down waste materials and cellular debris. In individuals with NCL, a genetic mutation such as in the CLN3 gene leads to the accumulation of substances that the lysosomes fail to degrade. This accumulation is believed to damage neurons, leading to the progressive symptoms observed in NCL. Understanding the genetic basis of NCL sheds light on how certain genes influence neuronal survival and function, highlighting the complexity of genetic diseases.

carrier genetic status

In autosomal recessive disorders like Neuronal ceroid lipofuscinosis (NCL), the concept of carrier genetic status is crucial. A carrier is an individual who has one normal allele and one mutated allele of a particular gene. Crucially, carriers do not exhibit symptoms of the disorder because the normal allele usually produces enough of the necessary protein to maintain normal function. This phenomenon explains why parents who are both carriers can appear completely normal, even though their child might inherit the disease. For an affected child to be born, both parents have to pass on the mutated allele, as having just one mutated allele is not enough to cause the disease symptoms. Thus, both parents must be carriers, each having a 50% chance of passing the mutated gene to their offspring. This understanding is vital in comprehending how autosomal recessive diseases persist in populations and helps in genetic counseling for families.

gene mutation analysis

Gene mutation analysis is a pivotal tool in understanding genetic diseases like Neuronal ceroid lipofuscinosis (NCL) and is essential for diagnosing carrier genetic status. This process involves examining an individual's DNA to identify mutations in specific genes, like CLN3, which is associated with NCL. Typically, genetic testing and analysis will focus on looking for known mutations that are linked to the disease phenotype. When parents are identified as carriers through gene mutation analysis, steps can be taken to understand the risks of passing the mutation to children. This can inform family planning and also allow for early interventions if a child is at risk. Gene mutation analysis not only helps in the diagnosis and management of genetic disorders but also furthers research into developing targeted therapies. As more is known about specific mutations associated with diseases such as NCL, it becomes possible to devise strategies for treatment and potentially even prevention in the future.